Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesViro-Immunologic Response to Ritonavir-Boosted or Unboosted Atazanavir in a Large Cohort of Multiply Treated Patients
AIDS Patient Care and STDs, 01/22/08
Santoro MM et al. - Currently, comparative data able to define the potency of boosted versus unboosted atazanavir in highly pretreated HIV-infected patients are limited. Specifically, in clinical practice it is very important to establish whether atazanavir-boosting with ritonavir warrants potency and efficacy that overcome the profile of unboosted drug
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
Annals of Pharmacotherapy, 11/25/09
Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Annals of Pharmacotherapy, 11/25/09
Sponsor
Article Search
Sponsor